Is Nestle S.A. a good investment? Nestle S.A. (NSRGY) is currently trading at 100.25 USD. Market analysts have a consensus price target of 113.20 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 22.00. This valuation is generally in line with the broader market.
Earnings Schedule: Nestle S.A. is expected to release its next earnings report on July 23, 2026. The market consensus estimate for Forward EPS is 6.08.
For income investors, Nestle S.A. pays a dividend yield of 3.88%. With a payout ratio of 87%, the dividend appears to be under pressure.
Yes, it pays an annual dividend of 3.10 USD (3.88% yield).
Nestle S.A. is classified as a Stock. You can compare it against 5 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be July 23, 2026. The company currently has a trailing EPS of 4.48.
Nestlé S.A., together with its subsidiaries, operates as a food and beverage company. It operates through Zone North America; Zone Europe; Zone Asia, Oceania and Africa; Zone Latin America; Zone Greater China; Nestlé Health Science; and Nespresso segments. It offers water under the Acqua Panna, Nestlé Pure Life, Perrier, S.Pellegrino, Sanpellegrino, and other local brands; and chocolate and confectionery products under the Aero, Baci Perugina, KitKat, Milkybar, Smarties, and other local brands; family nutrition products, including early childhood, kids and teenagers, and maternal and adult products; cereals; dairy and drink products; food services, such as coffee, beverages, and food; healthcare nutrition products comprising lifestyle and medical nutrition products; plant-based products; and recipes. The company also provides coffee products under the Blue Bottle Coffee, Nescafé, Nescafé Dolce Gusto, Nespresso, and Starbucks Coffee At Home brands; culinary, chilled, and frozen food products under the DiGiorno, Garden Gourmet, Maggi, Thomy, and other local brands; ice cream products under the Antica Gelateria Del Corso, Drumstick, Extrême, Häagen-Dazs, Maxibon, and Mövenpick brands; and pet care products under the Cat Chow, Dentalife, Dog Chow, Fancy Feast, Felix, Friskies, Gourmet, Purina, Purina ONE, Purina Pro Plan, Purina Pro Plan Veterinary Diets, and other local brands. The company was founded in 1866 and is headquartered in Vevey, Switzerland. Aimmune Therapeutics, Inc. operates as a subsidiary of Nestlé S.A.
| Year | Total Dividends |
|---|---|
| ▸2027 |
4.01 USD
|
| April 5, 2027 (estimated) | 4.0060 |
| ▸2026 |
4.01 USD
|
| April 21, 2026 | 4.0060 |
| ▸2025 |
3.40 USD
|
| May 29, 2025 | 3.3960 |
| ▸2024 |
3.41 USD
|
| May 31, 2024 | 3.4080 |
| ▸2023 |
3.19 USD
|
| June 8, 2023 | 3.1860 |
| ▸2022 |
3.04 USD
|
| May 24, 2022 | 3.0430 |
| ▸2021 |
3.07 USD
|
| May 27, 2021 | 3.0660 |
| ▸2020 |
2.76 USD
|
| June 5, 2020 | 2.7580 |
| ▸2019 |
2.42 USD
|
| May 24, 2019 | 2.4235 |
| ▸2018 |
2.53 USD
|
| May 25, 2018 | 2.5290 |
| ▸2017 |
2.30 USD
|
| May 19, 2017 | 2.3040 |
| ▸2016 |
2.26 USD
|
| May 20, 2016 | 2.2640 |
| ▸2015 |
2.32 USD
|
| May 29, 2015 | 2.3180 |
| ▸2014 |
2.42 USD
|
| May 29, 2014 | 2.4220 |
| ▸2013 |
2.18 USD
|
| May 24, 2013 | 2.1770 |
| ▸2012 |
2.11 USD
|
| May 23, 2012 | 2.1050 |
| ▸2011 |
1.92 USD
|
| May 25, 2011 | 1.9200 |
| ▸2010 |
1.49 USD
|
| April 19, 2010 | 1.4870 |
| ▸2009 |
1.20 USD
|
| April 24, 2009 | 1.1950 |
| ▸2008 |
1.21 USD
|
| April 11, 2008 | 1.2056 |
| ▸2007 |
0.86 USD
|
| April 20, 2007 | 0.8588 |
| ▸2006 |
0.69 USD
|
| March 31, 2006 | 0.6924 |
| ▸2005 |
0.67 USD
|
| April 8, 2005 | 0.6704 |
| ▸2004 |
0.56 USD
|
| April 16, 2004 | 0.5560 |
| ▸2003 |
0.53 USD
|
| March 28, 2003 | 0.5272 |
| ▸2002 |
0.38 USD
|
| April 5, 2002 | 0.3840 |
| ▸2001 |
0.32 USD
|
| March 30, 2001 | 0.3190 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Nestle S.A. | Apr 21, 2026 | Paid | 4.006 USD |
| Split Date | Split Ratio to 1 |
|---|---|
| June 11, 2001 | 2.000000 |
| July 3, 2008 | 2.500000 |
Community Discussion